Skip to main
IVVD
IVVD logo

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc. is positioned favorably in the biopharmaceutical market due to the continued efficacy of its leading candidate, PEMGARDA, which maintains neutralizing activity against dominant SARS-CoV-2 variants, ensuring relevance amid viral evolution. The company's commitment to developing innovative antibody-based solutions, particularly for immunocompromised individuals, suggests a robust potential revenue stream in a high-risk market segment. Additionally, positive expectations for the launch trajectory in 2025, coupled with strong Phase 3 data and a focus on unmet patient needs, reinforce a positive long-term outlook for Invivyd’s stock.

Bears say

Invivyd Inc. faces significant challenges due to regulatory setbacks, particularly the FDA's rejection of its request to expand the Emergency Use Authorization (EUA) for PEMGARDA, which limits its potential market and underscores the difficulties in securing approval for COVID-19 therapeutics. These setbacks reveal a reliance on a narrow pipeline that lacks diversification, highlighting the company's vulnerability in maintaining long-term growth and financial stability. Furthermore, despite positive clinical data supporting PEMGARDA's efficacy as a prophylactic treatment, the inability to address the treatment needs of immunocompromised patients with current offerings raises concerns about Invivyd's operational viability and attractiveness to investors.

Invivyd Inc (IVVD) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 5 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.